Plantarc Bio Ltd (PLNT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Plantarc Bio Ltd (PLNT) has a cash flow conversion efficiency ratio of -0.235x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.79 Million ≈ $-4.79K USD) by net assets (ILA7.61 Million ≈ $20.41K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Plantarc Bio Ltd net asset quality index to measure how much of total assets are equity-financed.
Plantarc Bio Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Plantarc Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Plantarc Bio Ltd (PLNT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Plantarc Bio Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Plantarc Bio Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Copper Lake Resources Ltd
V:CPL
|
-0.058x |
|
Alliance Mining Corp
V:ALM
|
0.002x |
|
WINDELN.DE SE INH O.N.
F:WDL1
|
N/A |
|
Medigene AG
XETRA:MDG1
|
-0.180x |
|
Capella Minerals Ltd
V:CMIL
|
0.133x |
|
Verney-Carron S.A
PA:MLVER
|
N/A |
|
Totalindo Eka Persada Tbk PT
JK:TOPS
|
-0.009x |
|
Helios Underwriting PLC
LSE:HUW
|
-0.486x |
Annual Cash Flow Conversion Efficiency for Plantarc Bio Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of Plantarc Bio Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Plantarc Bio Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA9.53 Million ≈ $25.54K |
ILA-1.47 Million ≈ $-3.95K |
-0.155x | +43.25% |
| 2023-12-31 | ILA11.96 Million ≈ $32.06K |
ILA-3.26 Million ≈ $-8.73K |
-0.272x | -10.60% |
| 2022-12-31 | ILA13.60 Million ≈ $36.46K |
ILA-3.35 Million ≈ $-8.98K |
-0.246x | -7.68% |
| 2021-12-31 | ILA17.72 Million ≈ $47.50K |
ILA-4.05 Million ≈ $-10.87K |
-0.229x | +84.32% |
| 2020-12-31 | ILA1.19 Million ≈ $3.20K |
ILA-1.74 Million ≈ $-4.66K |
-1.459x | -129.83% |
| 2019-12-31 | ILA3.29 Million ≈ $8.82K |
ILA-2.09 Million ≈ $-5.60K |
-0.635x | +39.03% |
| 2018-12-31 | ILA1.70 Million ≈ $4.57K |
ILA-1.77 Million ≈ $-4.75K |
-1.041x | -- |
About Plantarc Bio Ltd
PlantArc Bio Ltd. operates as an Ag-Bio company for the crop protection and yield enhancement. The company develops and operates a Direct-In-Plant gene discovery platform. It focuses on yield improvement, drought resistance, and herbicide and insects tolerance. The company was incorporated in 2014 and is based in Ra'anana, Israel.